MIT engineers design modular phage nanoparticles for personalized cancer vaccines
A reengineered M13 virus nanofiber coated with tunable densities of tumor antigens blocked colon tumor growth in mice, offering a customizable vaccine platform.
What to know
- The vaccine backbone is a modified, harmless bacteriophage (M13) engineered into a nanofiber scaffold that can be coated with cancer antigens.
- Controlling the density of antigens attached to the phage's pVIII capsid protein was key to generating a protective immune response in mice.
- The platform is modular, meaning antigens could in principle be swapped to create vaccines tailored to individual patients' specific tumors.
- Findings come from decades of work in Belcher's lab repurposing M13 phage scaffolds, previously used for batteries, solar cells and other materials, for medical/vaccine applications.
Angela Belcher Senior author, MIT professorShengnan Huang Lead author, research scientistJack Rudrum Co-author, graduate studentHuaiyao Peng Co-author, graduate studentHao Nghi Luu Co-author, graduate student
How it unfolded 3 developments, newest first · click a bar or a number to jump articlesposts
-
3
Story resurfaces on Hacker News
A link to the MIT News writeup was posted to Hacker News, though it drew no comments at the time captured.
“The great thing about this is that it’s modular and we could switch out different antigens on demand, so you could design it to be patient-specific and target a known antigen for a particular kind of cancer…”
— Angela Belcher, MIT professor, senior author · source - 2 days quiet
-
2
Coverage of the nanoparticle vaccine spreads via science press outlets
Phys.org, Nanowerk, Interesting Engineering and News-Medical republished or summarized the MIT findings, describing the phage nanofiber's potential for personalized cancer vaccines.
-
first by Phys.org, 9d ago · also Google News · Health
1 more headline
- Nanoscale particle shows potential as customizable delivery vehicle for personalized cancer vaccines - News-Medical Google News · Health · 8d ago
-
first by Interesting Engineering, 8d ago
-
-
background
Researchers explain how antigen density drives immune response — The team modified the phage's pVIII capsid protein to attach cancer antigens and found that precisely controlling antigen density on the nanofiber was critical to generating an effective immune response, building on prior lab findings.
-
1
MIT team publishes phage-based cancer vaccine nanoparticle study
Angela Belcher's lab at the Koch Institute, with lead author Shengnan Huang, published findings in Advanced Healthcare Materials describing an M13 bacteriophage nanofiber that can be coated with cancer antigens to prevent colon tumor development in mice.
-
first by Nanowerk, 9d ago
-
first by Mirage News, 9d ago
-